Share Price and Basic Stock Data
Last Updated: February 24, 2025, 9:15 pm
PEG Ratio | 0.05 |
---|
Competitors of Morgan Ventures Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Money Masters Leasing & Finance Ltd | 30.1 Cr. | 3.00 | 19.5/2.83 | 38.6 | 1.56 | 0.00 % | 2.57 % | 4.07 % | 1.00 |
Moneyboxx Finance Ltd | 556 Cr. | 170 | 373/158 | 52.2 | 81.0 | 0.00 % | 11.4 % | 7.45 % | 10.0 |
Moongipa Capital Finance Ltd | 17.9 Cr. | 19.5 | 41.0/17.7 | 9.22 | 8.69 | 0.00 % | 34.9 % | 31.6 % | 10.0 |
Morarka Finance Ltd | 46.1 Cr. | 102 | 191/100 | 16.5 | 387 | 5.85 % | 4.04 % | 3.58 % | 10.0 |
Morgan Ventures Ltd | 93.5 Cr. | 94.4 | 154/34.8 | 3.80 | 75.0 | 0.00 % | 10.5 % | 16.9 % | 10.0 |
Industry Average | 24,516.32 Cr | 531.56 | 36.87 | 539.62 | 0.27% | 19.61% | 10.68% | 8.56 |
Quarterly Result
Metric | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 5.10 | 4.11 | 6.25 | 9.00 | 7.04 | -3.69 | -0.36 | 3.59 | 3.93 | 4.56 | 10.91 | 5.89 | 12.48 |
Expenses | 0.06 | 0.05 | 1.34 | 0.05 | 0.07 | 0.07 | 2.12 | 0.08 | 0.10 | 0.06 | 0.17 | 0.83 | 0.12 |
Operating Profit | 5.04 | 4.06 | 4.91 | 8.95 | 6.97 | -3.76 | -2.48 | 3.51 | 3.83 | 4.50 | 10.74 | 5.06 | 12.36 |
OPM % | 98.82% | 98.78% | 78.56% | 99.44% | 99.01% | 97.77% | 97.46% | 98.68% | 98.44% | 85.91% | 99.04% | ||
Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.77 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 1.39 | 0.07 |
Interest | 0.93 | 1.55 | 1.06 | 0.62 | 0.35 | 0.54 | 0.85 | 1.46 | 1.61 | 2.04 | 3.62 | 2.36 | 3.72 |
Depreciation | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit before tax | 4.11 | 2.51 | 3.83 | 8.33 | 6.62 | -3.53 | -3.33 | 2.06 | 2.23 | 2.46 | 7.12 | 4.09 | 8.71 |
Tax % | -12.65% | 0.40% | 71.28% | 27.13% | 11.33% | -25.21% | -18.32% | 35.92% | 11.66% | 25.20% | 32.44% | -22.49% | 36.97% |
Net Profit | 4.63 | 2.50 | 1.10 | 6.07 | 5.87 | -2.64 | -2.72 | 1.32 | 1.98 | 1.84 | 4.81 | 5.01 | 5.50 |
EPS in Rs | 4.68 | 2.53 | 1.11 | 6.13 | 5.93 | -2.67 | -2.75 | 1.33 | 2.00 | 1.86 | 4.86 | 5.06 | 5.56 |
Last Updated: Unknown
Profit & Loss - Annual Report
Last Updated: February 20, 2025, 2:18 pm
Metric | Jun 2013 | Jun 2014 | Mar 2015n n 9m | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 4 | 4 | 1 | 0 | 0 | 0 | -3 | 1 | 6 | 17 | 12 | 23 | 44 |
Expenses | 3 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 0 | 1 |
Operating Profit | 1 | 3 | -1 | -0 | -0 | -0 | -3 | 1 | 6 | 15 | 10 | 23 | 43 |
OPM % | 22% | 63% | -196% | -2,900% | 77% | 95% | 91% | 81% | 98% | 97% | |||
Other Income | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 4 | 2 | 9 | 12 |
Depreciation | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit before tax | -0 | 2 | -1 | 0 | 0 | 0 | -3 | -0 | 3 | 11 | 8 | 14 | 32 |
Tax % | -121% | 1% | 65% | 17% | 33% | 0% | -27% | 100% | 50% | 25% | 19% | 28% | |
Net Profit | 0 | 2 | -2 | 0 | 0 | 0 | -2 | -0 | 1 | 8 | 7 | 10 | 25 |
EPS in Rs | 0.05 | 1.55 | -2.25 | 0.06 | 0.03 | 0.01 | -2.30 | -0.10 | 1.47 | 8.44 | 6.65 | 10.05 | 24.85 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
Year | 2019-2020 | 2021-2022 | 2022-2023 | 2023-2024 |
---|---|---|---|---|
YoY Net Profit Growth (%) | 100.00% | 700.00% | -12.50% | 42.86% |
Change in YoY Net Profit Growth (%) | 0.00% | 600.00% | -712.50% | 55.36% |
Morgan Ventures Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 4 years from 2019-2020 to 2023-2024.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 19% |
5 Years: | % |
3 Years: | 58% |
TTM: | 273% |
Compounded Profit Growth | |
---|---|
10 Years: | 70% |
5 Years: | 45% |
3 Years: | 90% |
TTM: | 917% |
Stock Price CAGR | |
---|---|
10 Years: | 32% |
5 Years: | 68% |
3 Years: | 45% |
1 Year: | 117% |
Return on Equity | |
---|---|
10 Years: | 5% |
5 Years: | 11% |
3 Years: | 16% |
Last Year: | 17% |
Last Updated: Unknown
Balance Sheet
Last Updated: Unknown
Month | Jun 2013 | Jun 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
Reserves | 30 | 31 | 29 | 29 | 29 | 29 | 28 | 27 | 29 | 37 | 44 | 54 | 64 |
Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38 | 36 | 108 | 156 | 156 | 145 |
Other Liabilities | 11 | 12 | 10 | 9 | 0 | 0 | 0 | 0 | 1 | 4 | 6 | 9 | 27 |
Total Liabilities | 51 | 53 | 49 | 48 | 39 | 39 | 38 | 76 | 76 | 159 | 216 | 229 | 247 |
Fixed Assets | 11 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20 |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 8 | 9 | 11 | 9 | 2 | 2 | 0 | 51 | 53 | 139 | 197 | 210 | 224 |
Other Assets | 32 | 35 | 38 | 39 | 37 | 37 | 37 | 24 | 23 | 20 | 19 | 19 | 2 |
Total Assets | 51 | 53 | 49 | 48 | 39 | 39 | 38 | 76 | 76 | 159 | 216 | 229 | 247 |
Cash Flow
Month | Jun 2013 | Jun 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Jun 2013 | Jun 2014 | Mar 2015n n 9m | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | 1.00 | 3.00 | -1.00 | 0.00 | 0.00 | 0.00 | -3.00 | -37.00 | -30.00 | -93.00 | -146.00 | -133.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Jun 2013 | Jun 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 81 | 72 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Inventory Days | -2,230 | |||||||||||
Days Payable | ||||||||||||
Cash Conversion Cycle | 81 | 72 | 0 | 0 | -2,230 | 0 | 0 | 0 | 0 | 0 | ||
Working Capital Days | 1,416 | 1,361 | 11,065 | 658,460 | 4,421 | 7,347 | 1,441 | 415 | 539 | 282 | ||
ROCE % | 0% | 4% | -3% | 0% | 0% | 0% | -8% | 2% | 7% | 13% | 5% | 11% |
This stock is not held by any mutual fund
Key Financial Ratios
Month | Mar 16 | Mar 15 | Jun 14 | Jun 13 | Jun 12 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 0.04 | -2.41 | 1.75 | -0.23 | 1.29 |
Diluted EPS (Rs.) | 0.04 | -2.41 | 1.75 | -0.23 | 1.29 |
Cash EPS (Rs.) | 0.06 | -2.12 | 2.56 | 1.08 | 2.81 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 39.21 | 39.17 | 41.48 | 39.99 | 39.95 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 39.21 | 39.17 | 41.48 | 39.99 | 39.95 |
Revenue From Operations / Share (Rs.) | 0.00 | 0.54 | 4.18 | 4.13 | 4.00 |
PBDIT / Share (Rs.) | 0.01 | -1.34 | 2.84 | 0.88 | 2.92 |
PBIT / Share (Rs.) | 0.00 | -1.53 | 1.77 | -0.19 | 1.83 |
PBT / Share (Rs.) | 0.00 | -1.53 | 1.77 | -0.58 | 1.17 |
Net Profit / Share (Rs.) | 0.04 | -2.31 | 1.49 | 0.00 | 1.72 |
NP After MI And SOA / Share (Rs.) | 0.04 | -2.31 | 1.49 | 0.00 | 1.72 |
PBDIT Margin (%) | 0.00 | -246.91 | 68.05 | 21.43 | 73.09 |
PBIT Margin (%) | 0.00 | -281.26 | 42.39 | -4.83 | 45.73 |
PBT Margin (%) | 0.00 | -281.31 | 42.38 | -14.09 | 29.19 |
Net Profit Margin (%) | 0.00 | -425.48 | 35.68 | -0.05 | 42.89 |
NP After MI And SOA Margin (%) | 0.00 | -425.48 | 35.68 | -0.05 | 42.89 |
Return on Networth / Equity (%) | 0.10 | -5.89 | 3.59 | 0.00 | 4.29 |
Return on Capital Employeed (%) | 0.00 | -3.15 | 3.11 | -0.35 | 3.11 |
Return On Assets (%) | 0.08 | -4.60 | 2.46 | 0.00 | 2.83 |
Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.15 | 0.15 | 0.21 |
Total Debt / Equity (X) | 0.00 | 0.00 | 0.17 | 0.15 | 0.21 |
Asset Turnover Ratio (%) | 0.00 | 0.01 | 0.07 | 0.07 | 0.07 |
Current Ratio (X) | 2.49 | 13.52 | 5.19 | 8.13 | 11.95 |
Quick Ratio (X) | 0.62 | 3.61 | 0.27 | 0.60 | 1.73 |
Interest Coverage Ratio (X) | 67.43 | -4912.48 | 9984.77 | 2.31 | 4.42 |
Interest Coverage Ratio (Post Tax) (X) | -11.85 | -8831.33 | 6145.96 | 0.38 | 3.59 |
Enterprise Value (Cr.) | 7.47 | -1.79 | 14.72 | 11.69 | 11.19 |
EV / Net Operating Revenue (X) | 0.00 | -3.32 | 3.56 | 2.86 | 2.81 |
EV / EBITDA (X) | 404.43 | 1.35 | 5.23 | 13.33 | 3.84 |
MarketCap / Net Operating Revenue (X) | 0.00 | 8.13 | 1.88 | 1.50 | 0.73 |
Price / BV (X) | 0.33 | 0.11 | 0.18 | 0.15 | 0.07 |
Price / Net Operating Revenue (X) | 0.00 | 8.14 | 1.88 | 1.50 | 0.73 |
EarningsYield | 0.00 | -0.52 | 0.19 | 0.00 | 0.58 |
After reviewing the key financial ratios for Morgan Ventures Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 16, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 15) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 16, the value is 0.04. This value is below the healthy minimum of 5. It has increased from -2.41 (Mar 15) to 0.04, marking an increase of 2.45.
- For Diluted EPS (Rs.), as of Mar 16, the value is 0.04. This value is below the healthy minimum of 5. It has increased from -2.41 (Mar 15) to 0.04, marking an increase of 2.45.
- For Cash EPS (Rs.), as of Mar 16, the value is 0.06. This value is below the healthy minimum of 3. It has increased from -2.12 (Mar 15) to 0.06, marking an increase of 2.18.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 16, the value is 39.21. It has increased from 39.17 (Mar 15) to 39.21, marking an increase of 0.04.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 16, the value is 39.21. It has increased from 39.17 (Mar 15) to 39.21, marking an increase of 0.04.
- For Revenue From Operations / Share (Rs.), as of Mar 16, the value is 0.00. It has decreased from 0.54 (Mar 15) to 0.00, marking a decrease of 0.54.
- For PBDIT / Share (Rs.), as of Mar 16, the value is 0.01. This value is below the healthy minimum of 2. It has increased from -1.34 (Mar 15) to 0.01, marking an increase of 1.35.
- For PBIT / Share (Rs.), as of Mar 16, the value is 0.00. This value is within the healthy range. It has increased from -1.53 (Mar 15) to 0.00, marking an increase of 1.53.
- For PBT / Share (Rs.), as of Mar 16, the value is 0.00. This value is within the healthy range. It has increased from -1.53 (Mar 15) to 0.00, marking an increase of 1.53.
- For Net Profit / Share (Rs.), as of Mar 16, the value is 0.04. This value is below the healthy minimum of 2. It has increased from -2.31 (Mar 15) to 0.04, marking an increase of 2.35.
- For NP After MI And SOA / Share (Rs.), as of Mar 16, the value is 0.04. This value is below the healthy minimum of 2. It has increased from -2.31 (Mar 15) to 0.04, marking an increase of 2.35.
- For PBDIT Margin (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -246.91 (Mar 15) to 0.00, marking an increase of 246.91.
- For PBIT Margin (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -281.26 (Mar 15) to 0.00, marking an increase of 281.26.
- For PBT Margin (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -281.31 (Mar 15) to 0.00, marking an increase of 281.31.
- For Net Profit Margin (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 5. It has increased from -425.48 (Mar 15) to 0.00, marking an increase of 425.48.
- For NP After MI And SOA Margin (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 8. It has increased from -425.48 (Mar 15) to 0.00, marking an increase of 425.48.
- For Return on Networth / Equity (%), as of Mar 16, the value is 0.10. This value is below the healthy minimum of 15. It has increased from -5.89 (Mar 15) to 0.10, marking an increase of 5.99.
- For Return on Capital Employeed (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -3.15 (Mar 15) to 0.00, marking an increase of 3.15.
- For Return On Assets (%), as of Mar 16, the value is 0.08. This value is below the healthy minimum of 5. It has increased from -4.60 (Mar 15) to 0.08, marking an increase of 4.68.
- For Long Term Debt / Equity (X), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 15) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 16, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 15) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 16, the value is 0.00. It has decreased from 0.01 (Mar 15) to 0.00, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 16, the value is 2.49. This value is within the healthy range. It has decreased from 13.52 (Mar 15) to 2.49, marking a decrease of 11.03.
- For Quick Ratio (X), as of Mar 16, the value is 0.62. This value is below the healthy minimum of 1. It has decreased from 3.61 (Mar 15) to 0.62, marking a decrease of 2.99.
- For Interest Coverage Ratio (X), as of Mar 16, the value is 67.43. This value is within the healthy range. It has increased from -4,912.48 (Mar 15) to 67.43, marking an increase of 4,979.91.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 16, the value is -11.85. This value is below the healthy minimum of 3. It has increased from -8,831.33 (Mar 15) to -11.85, marking an increase of 8,819.48.
- For Enterprise Value (Cr.), as of Mar 16, the value is 7.47. It has increased from -1.79 (Mar 15) to 7.47, marking an increase of 9.26.
- For EV / Net Operating Revenue (X), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 1. It has increased from -3.32 (Mar 15) to 0.00, marking an increase of 3.32.
- For EV / EBITDA (X), as of Mar 16, the value is 404.43. This value exceeds the healthy maximum of 15. It has increased from 1.35 (Mar 15) to 404.43, marking an increase of 403.08.
- For MarketCap / Net Operating Revenue (X), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 8.13 (Mar 15) to 0.00, marking a decrease of 8.13.
- For Price / BV (X), as of Mar 16, the value is 0.33. This value is below the healthy minimum of 1. It has increased from 0.11 (Mar 15) to 0.33, marking an increase of 0.22.
- For Price / Net Operating Revenue (X), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 8.14 (Mar 15) to 0.00, marking a decrease of 8.14.
- For EarningsYield, as of Mar 16, the value is 0.00. This value is below the healthy minimum of 5. It has increased from -0.52 (Mar 15) to 0.00, marking an increase of 0.52.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation. If you have any questions or need more detailed insights, please feel free to reach out.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Morgan Ventures Ltd:
- Net Profit Margin: 0%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0% (Industry Average ROCE: 19.61%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.1% (Industry Average ROE: 10.68%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -11.85
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.62
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 3.8 (Industry average Stock P/E: 36.87)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Non-Banking Financial Company (NBFC) | 37, Ring Road, New Delhi Delhi 110024 | morgan@morganventures.in http://www.morganventures.in |
Management | |
---|---|
Name | Position Held |
Mr. Kuldeep Kumar Dhar | Managing Director |
Mr. Sanjiv Bansal | Independent Director |
Mr. Krishan Kumar Gupta | Independent Director |
Mrs. Madhu | Woman Director |
FAQ
What is the latest intrinsic value of Morgan Ventures Ltd?
Let's break down Morgan Ventures Ltd's intrinsic value simply:
We calculate intrinsic value using the PE Ratio Method - comparing the company's current price-to-earnings ratio with its historical average and industry peers. Think of it like checking if a stock is "on sale" compared to its typical pricing.
As of 24 February 2025:
- Calculated Fair Value: ₹39.30
- Current Market Price: ₹94.40
- Variance: 58.37% lower
This suggests Morgan Ventures Ltd is currently overvalued by 58.37%. For context:
- Market Cap: 93.5 Cr.
- 52-Week Range: 154/34.8
- Reserves (Sep 2024): ₹64 Cr
- Liabilities: 247 Cr
Remember: The PE method gives a snapshot based on earnings multiples. While useful for quick comparisons, investors should also consider growth prospects, industry trends, and economic conditions. This calculation assumes historical PE ratios remain relevant - always verify with current market dynamics.
What is the Market Cap of Morgan Ventures Ltd?
The Market Cap of Morgan Ventures Ltd is 93.5 Cr..
What is the current Stock Price of Morgan Ventures Ltd as on 24 February 2025?
The current stock price of Morgan Ventures Ltd as on 24 February 2025 is ₹94.4.
What is the High / Low of Morgan Ventures Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of Morgan Ventures Ltd stocks is 154/34.8.
What is the Stock P/E of Morgan Ventures Ltd?
The Stock P/E of Morgan Ventures Ltd is 3.80.
What is the Book Value of Morgan Ventures Ltd?
The Book Value of Morgan Ventures Ltd is 75.0.
What is the Dividend Yield of Morgan Ventures Ltd?
The Dividend Yield of Morgan Ventures Ltd is 0.00 %.
What is the ROCE of Morgan Ventures Ltd?
The ROCE of Morgan Ventures Ltd is 10.5 %.
What is the ROE of Morgan Ventures Ltd?
The ROE of Morgan Ventures Ltd is 16.9 %.
What is the Face Value of Morgan Ventures Ltd?
The Face Value of Morgan Ventures Ltd is 10.0.